The FcRn-specific human antibody target FcRn which is a receptor with a high affinity for IgG. The binding of the antibody to FcRn can reduce serum pathogenic auto-antibody levels, and therefore can be used to treat autoimmune diseases such as immune neutropenia, Guillain-Barre syndrome, epilepsy, autoimmune encephalitis, Isaac's syndrome, nevus syndrome, pemphigus vulgaris and so on.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For research use only. Not intended for any clinical use.